Corrigendum to “Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns” [Brain Behav. Immun. 24 (2010) 784–791]

Corrigendum to “Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns” [Brain Behav. Immun. 24 (2010) 784–791]

Brain, Behavior, and Immunity 25 (2011) 1044 Contents lists available at ScienceDirect Brain, Behavior, and Immunity journal homepage: www.elsevier...

120KB Sizes 0 Downloads 24 Views

Brain, Behavior, and Immunity 25 (2011) 1044

Contents lists available at ScienceDirect

Brain, Behavior, and Immunity journal homepage: www.elsevier.com/locate/ybrbi

Corrigendum

Corrigendum to ‘‘Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns’’ [Brain Behav. Immun. 24 (2010) 784–791] Insa Hoffmann a, Wolfgang Bueter b, Katja Zscheppang a, Maria-Jantje Brinkhaus b, Andrea Liese a, Stefan Riemke b, Thilo Dörk c, Olaf Dammann b,d,e,⇑,1, Christiane E.L. Dammann a,d,1 a

Pediatric Pulmonology and Neonatology, Hannover Medical School, Hannover, Germany Perinatal Neuroepidemiology Unit, Hannover Medical School, Hannover, Germany Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany d Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA e Neuroepidemiology Unit, Children’s Hospital, Boston, MA, USA b c

In the original publication, the wrong antibodies were listed in the section ‘‘Methods and patients; 2.4. ELISA’’. All experiments were performed using the R&D DuoSet ELISA Kit which includes the specific antibodies. The antibodies provided with the R&D DuoSet ELISA kit were used exclusively. There was no exchange of antibodies as indicated in the paper. This section should read as below.

DOI of original article: 10.1016/j.bbi.2009.08.012

⇑ Corresponding author at: Floating Hospital for Children at Tufts Medical Center, 800 Washington Street, Box 854, Boston, MA 02111, USA. Fax: +1 617 6363309. E-mail address: [email protected] (O. Dammann). 1 These two authors contributed equally to this paper. 0889-1591/$ - see front matter Ó 2009 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2011.03.011

[. . .] 96-well-plates were coated overnight with 100 ll capture antibody (4 lg/ml, included within the R&D ELISA kit) at 4 °C. After overnight blocking with 1% protease-free BSA and 5% sucrose, 100 ll of sample or standard were incubated overnight at 4 °C. One hundred microliters detection antibody (150 ng/ml, included within the R&D ELISA kit), solved in PBS with 1% protease-free BSA and 2% normal goat serum was added for 2 hr. [. . .]